Biocraft Laboratories Inc said it signed a contract with American Cyanamid Co to make cefixime, a third generation oral cephalosporin. It said American Cyanamid's Lederle Laboratories filed a new drug application with the Food and Drug Administration for the product. According to the agreement, Biocraft will manufacture the product for American Cyanamid for the first three years of commercial production. 